SARS-CoV-2 diagnostics: performance data
To complement these evaluations, and in partnership with WHO in line with our official Collaborating Centre remit, we endeavored to centralize the collection of independently generated SARS-CoV-2 diagnostic performance data as a global public good. On 27 March 2020, we published an open call to partners and laboratories around the world for any performance data on commercially available in vitro diagnostic tests for SARS-CoV-2 that detect nucleic acid, viral antigen or antibodies.
In partnership with McGill University, we also included publicly available data (either published or shared on preprint servers) up until 1 August 2020. For ongoing reviews of data in the public domain, please refer to the Cochrane Library which is publishing multiple diagnostic reviews. For example:
- Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection
- Antibody tests for identification of current and past infection with SARS‐CoV‐2
- Routine laboratory testing to determine if a patient has COVID-19 pneumonia or SARS-CoV-2 infection
All data from independent institutions are welcome, with as much detail as possible.
Submitted data will be made openly accessible on a regular basis to enable fast data sharing throughout the diagnostic community.
—ICMJE guidelines clarify that in the context of a public health emergency, information with immediate implications for public health should be disseminated without concern that this will prejudice subsequent journal publication.
—Data are presented as published/shared on preprint servers/submitted to FIND – we have not verified quality and accuracy of data provided by third parties. Presentation of these data on our website does not impact any data ownership rights and FIND is not responsible for any use by any third party of these data. Data sources are provided.
SARS-CoV-2 diagnostic performance data
Data are being uploaded to this dashboard on a regular basis. Please note that the data displayed here are limited to essential information for better viewing. All available data can be viewed by downloading the data set.
As of 4 June 2020, 24 institutions have contributed data:
For questions relating to the collection or sharing of performance data for SARS-CoV-2 diagnostics, please contact us.